![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}
Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Workday
WDAY
5
eBay
EBAY
US Stock MarketDetailed Quotes
STTK Shattuck Labs
- 0.8309
- +0.0268+3.33%
Close Apr 29 16:00 ET
39.80MMarket Cap-0.56P/E (TTM)
0.8567High0.7800Low64.28KVolume0.7800Open0.8041Pre Close52.92KTurnover0.27%Turnover RatioLossP/E (Static)47.90MShares11.760052wk High0.50P/B20.09MFloat Cap0.692252wk Low--Dividend TTM24.18MShs Float60.5162Historical High--Div YieldTTM9.54%Amplitude0.6922Historical Low0.8230Avg Price1Lot Size
Shattuck Labs Stock Forum
Sign in to post a comment
$Shattuck Labs (STTK.US)$
Shattuck Labs Announces Positive Data from the Preclinical GLP Toxicology Study of SL-325 at the 20th Congress of European Crohn's and Colitis Organization (ECCO) in Inflammatory Bowel Diseases 2025
Thursday, 20th February at 9:00 am
– SL-325 is a high-affinity DR3 blocking antibody being developed for the treatment of inflammatory bowel disease (IBD); No evidence of toxicity or residual agonism observed in non-human primate toxicology study –
– SL-325 receptor occu...
Shattuck Labs Announces Positive Data from the Preclinical GLP Toxicology Study of SL-325 at the 20th Congress of European Crohn's and Colitis Organization (ECCO) in Inflammatory Bowel Diseases 2025
Thursday, 20th February at 9:00 am
– SL-325 is a high-affinity DR3 blocking antibody being developed for the treatment of inflammatory bowel disease (IBD); No evidence of toxicity or residual agonism observed in non-human primate toxicology study –
– SL-325 receptor occu...
4
$Shattuck Labs (STTK.US)$ next catalyst tomorrow, the price moving upward since last week. great cash position, we shall see market reaction tomorow.
1
2
$Shattuck Labs (STTK.US)$ Upcoming Scientific Presentations
Abstract accepted for poster presentation at the upcoming Crohn's and Colitis Congress, to be held February 6–8, 2025 in San Francisco, CA.Abstract accepted for oral presentation at the upcoming20th European Crohn's and Colitis Organization Congress, to be held February 19–22, 2025 in Berlin, Germany.
Upcoming Investor Conference Pre...
Abstract accepted for poster presentation at the upcoming Crohn's and Colitis Congress, to be held February 6–8, 2025 in San Francisco, CA.Abstract accepted for oral presentation at the upcoming20th European Crohn's and Colitis Organization Congress, to be held February 19–22, 2025 in Berlin, Germany.
Upcoming Investor Conference Pre...
5
NOTE!
1. NFA (Not Financial Advice!)
2. Do NOT open position WITHOUT chart confirmation, indicators, momentum.
3. Scale out and secure profits.
4. Most importantly, DON’T BLAME ME for your losses. Your trade, your accountability.
5. I DO NOT give buy or sell advice
6 COH (cash on hand); AH (after hours): RTH (regular trading hours); PR (press release; FCF (free cash flow)
7. NEVER be a blind follower.
LASTLY, If you don’t a...
1. NFA (Not Financial Advice!)
2. Do NOT open position WITHOUT chart confirmation, indicators, momentum.
3. Scale out and secure profits.
4. Most importantly, DON’T BLAME ME for your losses. Your trade, your accountability.
5. I DO NOT give buy or sell advice
6 COH (cash on hand); AH (after hours): RTH (regular trading hours); PR (press release; FCF (free cash flow)
7. NEVER be a blind follower.
LASTLY, If you don’t a...
74
30
10
holding at $1
1
quit selling u stupid fks
2
5
$Shattuck Labs (STTK.US)$
Shattuck Labs Provides Company Update and Announces SL-325, a First-In-Class Death Receptor 3 (DR3) Antagonist Targeting the TL1A/DR3 Signaling Pathway
Shattuck Labs (Nasdaq: STTK) announced a strategic pipeline prioritization, discontinuing its SL-172154 clinical program due to modest improvements in overall survival for TP53 mutant AML and HR-MDS patients. The company will focus on SL-325, a first-in-class DR3 antagonist antibody for inflammatory bowel disease (IBD...
Shattuck Labs Provides Company Update and Announces SL-325, a First-In-Class Death Receptor 3 (DR3) Antagonist Targeting the TL1A/DR3 Signaling Pathway
Shattuck Labs (Nasdaq: STTK) announced a strategic pipeline prioritization, discontinuing its SL-172154 clinical program due to modest improvements in overall survival for TP53 mutant AML and HR-MDS patients. The company will focus on SL-325, a first-in-class DR3 antagonist antibody for inflammatory bowel disease (IBD...
$Shattuck Labs (STTK.US)$ Officer Schreiber Taylor purchased 14,400 shares of common stock on Jun 26, 2024 at an average price of $3.473 for a total value of $50,011.2.
No comment yet
Market Insights
Discussing
Trade war escalates: What’s next for Chinese stocks?
🎙️Discussion 1. China-EU EV negotiations kick off recently. How do you think the negotiations will impact the performance of related stocks
Moo Earnings
Feb 17 19:21
Alibaba Q4 FY2024 Earnings Preview: Predict & Win Big! 🚀
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
VanCan2025 : in the fall, or at least by the end of the year, $5 peanuts for STTK - they've got a med breakthrough and will payoff